½ÃÀ庸°í¼­
»óǰÄÚµå
1589260

¼¼°èÀÇ »çÀ̹ö ³ªÀÌÇÁ ½ÃÀå : ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Cyberknife Market by Application (Brain Cancer, Liver Cancer, Lung Cancer), End User (Ambulatory Surgical Center, Clinic, Hospital) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 198 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

»çÀ̹ö ³ªÀÌÇÁ ½ÃÀåÀº 2023³â¿¡ 3¾ï 6,106¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 4¾ï 4,810¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 24.50%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 16¾ï 7,422¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

»çÀ̹ö ³ªÀÌÇÁ´Â Àü½Å Á¾¾ç°ú º´º¯À» ºñ ħ½ÀÀûÀ¸·Î Ä¡·áÇϱâ À§ÇØ °í¾ÈµÈ °í±Þ ·Îº¿ ¹æ»ç¼± ¼ö¼ú ½Ã½ºÅÛÀÔ´Ï´Ù. ¿¡ ¸Â´Â ¿É¼ÇÀ» Á¦°øÇÏ´Â µ¥ÀÖ¾î ȸº¹ ½Ã°£À» ´ÜÃàÇϰí ÁÖº¯ °Ç°­ÇÑ Á¶Á÷¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÃÖ¼ÒÈ­Çϸ鼭 ¼ö¼ú ºÒ°¡´ÉÇÑ Á¾¾çÀ» Ÿ°ÙÀ¸·Î ±× Àû¿ë ¹üÀ§´Â ³ú, ôÃß, Æó, Àü¸³¼± µî Á¤¹ÐÇÑ °í¼±·® ¹æ»ç¼±À» ÇÊ¿ä·Î ÇÏ´Â ¿µ¿ªÀÇ Ä¡·á¿¡ À̸¥´Ù »çÀ̹ö ³ªÀÌÇÁÀÇ ÃÖÁ¾ ¿ëµµ¿¡´Â ÁÖ·Î º´¿ø, ¾Ï Àü¹® Ä¡·á ¼¾ÅÍ, ¿¬±¸ ±â°üÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù ½ÃÀå ÀλçÀÌÆ®¿¡ µû¸£¸é, ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î ¾Ï À¯º´·ü Áõ°¡, ºñ ħ½ÀÀû Ä¡·á ¿É¼ÇÀÇ Ã¤Åà Ȯ´ë, ±â¼úÀÇ Áøº¸°¡ ½Ã»çµÇ°í ÀÖ½À´Ï´Ù. ·ç½ºÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖ´Â ½ÅÈï ½ÃÀåÀº Å« ºñÁî´Ï½º ±âȸÀÔ´Ï´Ù.¶ÇÇÑ, Çõ½ÅÀûÀÎ ¾Ï Ä¡·á¿¡ ´ëÇÑ Á¤ºÎ Áö¿ø Áõ°¡³ª °í·ÉÈ­°¡ ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ºñ¿ë, ¼÷·ÃµÈ Àü¹®°¡ÀÇ Çʿ伺, ´ëü Ä¡·á¿ÍÀÇ °æÀï°ú °°Àº °úÁ¦µµ Å« °¡ÁßÄ¡¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ±â°ü°úÀÇ Çù·Â ÆÄÆ®³Ê½Ê¿¡ ÃÊÁ¡À» ¸ÂÃß°í ¹æ»ç¼± ¼ö¼úÀÇ ÀÌÁ¡¿¡ ´ëÇÑ È¯ÀÚ ±³À°À» °­È­Çϰí AI ±â¹Ý Á¤¹Ð ±â¼ú Çâ»ó¿¡ ÅõÀÚÇØ¾ßÇÕ´Ï´Ù. °³¹ß,º¸´Ù ±¤¹üÀ§ÇÑ Á¾¾ç ÀÀ¿ëÀ»À§ÇÑ ½Ã½ºÅÛÀÇ ¹ü¿ë¼º Çâ»ó°ú °°Àº ºÐ¾ß¿¡¼­ Çõ½ÅÀÌ ²ÉÀ» ¿­ ¼ö ÀÖ½À´Ï´Ù.°æÀï ±¸µµÀº ¿ªµ¿ÀûÀÌ¸ç ±âÁ¸ ´ë±â¾÷Àº ½ÃÀå ÁÖµµ±ÇÀ» À¯ÁöÇϱâ À§ÇØ Ç÷§ÆûÀ» Áö¼ÓÀûÀ¸·Î ¾÷µî±ÞÇϰí ÀÖ½À´Ï´Ù. »ç¿ëÀÚ ¼·Ã븦 ÃËÁøÇÏ°í ½ÃÀå ħÅõ¸¦ È®´ë Çö½ÇÀûÀÎ °úÁ¦¸¦ ±Øº¹Çϱâ À§Çؼ­´Â °¡Ä¡°ü¿¡ ±âÃÊÇÑ ÇコÄɾî Á¦°øÀ̳ª ȯÀÚÀÇ ¼Ó¼º¿¡ µû¸¥ Ä¿½ºÅ͸¶ÀÌÁî¿¡ ÀÓÇÏ´Â °ÍÀÌ ÃßõÀÔ´Ï´Ù. ±×¸®°í Çõ½Å¿¡ ÀûÀÀÇÏ´Â °ÍÀº Áö¼ÓÀûÀÎ ¼ºÀåÀ» À§ÇØ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 3¾ï 6,106¸¸ ´Þ·¯
¿¹Ãø³â(2024) 4¾ï 4,810¸¸ ´Þ·¯
¿¹Ãø³â(2030) 16¾ï 7,422¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 24.50%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â »çÀ̹ö ³ªÀÌÇÁ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

»çÀ̹ö ³ªÀÌÇÁ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ±×¸®°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾ò±â À§ÇØ Áغñ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°èÀÇ Á¾¾ç¾Ï ȯÀÚ Áõ°¡
    • ÃâÇ÷ ¾øÀ½, Àý°³ ¾øÀ½, ÀÔ¿ø ¾øÀ½ µîÀÇ ÀÌÁ¡¿¡ ±âÀÎÇÏ´Â ÀáÀçÀû ¼ö¿ä
    • Àúħ½À ¼ö¼úÀÇ ÀÌ¿ë °¡´É¼º°ú ±âÈ£¼º
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • »çÀ̹ö ³ªÀÌÇÁ ÀýÂ÷¿¡ ´ëÇÑ ³·Àº ÀÎÁöµµ¿Í ´Ù¸¥ ÀýÂ÷¿¡ ºñÇØ ¸Å¿ì ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • ½ÅÁ¦Ç° °³¹ß ¹× ¼Ò°³¿¡ ´ëÇÑ Á¤ºÎ ¹× ¹Î°£ÀÇ Áö¼ÓÀûÀÎ ÀÚ±Ý Áö¿ø
    • ¼ö¼úÀÇ Á¤¹Ðµµ¸¦ Çâ»ó½ÃŰ´Â ±â¼úÀÇ Áøº¸
  • ½ÃÀåÀÇ °úÁ¦
    • ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·°ú Á¶Á÷À̳ª ±ÔÁ¦±â°ü¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Forces : »çÀ̹ö ³ªÀÌÇÁ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : »çÀ̹ö ³ªÀÌÇÁ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº »çÀ̹ö ³ªÀÌÇÁ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® »çÀ̹ö ³ªÀÌÇÁ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

»çÀ̹ö ³ªÀÌÇÁ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º »çÀ̹ö ³ªÀÌÇÁ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â »çÀ̹ö ³ªÀÌÇÁ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå »çÀ̹ö ³ªÀÌÇÁ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

»çÀ̹ö ³ªÀÌÇÁ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è¿¡¼­ Á¾¾ç¾Ï ȯÀÚ°¡ Áõ°¡
      • ÃâÇ÷À̳ª Àý°³, ÀÔ¿øÀÌ ºÒÇÊ¿ä µîÀÇ ÀÌÁ¡À¸·ÎºÎÅÍ ÀáÀçÀûÀÎ ¼ö¿ä°¡ »ý±ä´Ù
      • Àúħ½À ¼ö¼úÀÇ °¡¿ë¼º°ú ÃëÇâ
    • ¾ïÁ¦¿äÀÎ
      • »çÀ̹ö ³ªÀÌÇÁ ÀýÂ÷¿¡ ´ëÇÑ ÀÎÁöµµ°¡ ³·Àº °Í°ú ´Ù¸¥ ÀýÂ÷¿¡ ºñÇØ ºñ¿ëÀÌ ¸Å¿ì ³ôÀº °Í
    • ±âȸ
      • ½ÅÁ¦Ç° °³¹ß ¹× ¼Ò°³¸¦ À§ÇÑ Á¤ºÎ¿Í ¹Î°£ÀÇ Áö¼ÓÀûÀÎ ÀÚ±Ý Á¦°ø
      • ¼ø¼­ÀÇ Á¤¹Ðµµ¸¦ Çâ»ó½ÃŰ´Â ±â¼úÀÇ Áøº¸
    • °úÁ¦
      • ¼÷·ÃµÈ Àü¹®Áö½ÄÀÇ ºÎÁ·°ú Á¶Á÷ ¹× ±ÔÁ¦±â°ü¿¡ ´ëÇÑ ¿ì·Á
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå »çÀ̹ö ³ªÀÌÇÁ ½ÃÀå : ¿ëµµº°

  • ³úÁ¾¾ç
  • °£¾Ï
  • Æó¾Ï
  • ÃéÀå¾Ï

Á¦7Àå »çÀ̹ö ³ªÀÌÇÁ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ŭ¸®´Ð
  • º´¿ø
  • ¹æ»ç¼±Ä¡·á¼¾ÅÍ

Á¦8Àå ¾Æ¸Þ¸®Ä« »çÀ̹ö ³ªÀÌÇÁ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾ç »çÀ̹ö ³ªÀÌÇÁ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« »çÀ̹ö ³ªÀÌÇÁ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Accuray Incorporated
  • Alaska CyberKnife Center
  • Apollo Hospitals Enterprise Ltd
  • Elekta Solutions AB
  • Healthcare Global Enterprises Ltd.
  • IBA Dosimetry GmbH
  • InterTerra Medical Technologies(India), Pvt. Ltd.
  • MedStar Health Inc.
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • Nordion(Canada) Inc. by Sotera Health
  • Phoenix CyberKnife, Inc.
  • RaySearch Laboratories AB
  • Smith Nephew PLC
  • Varian Medical Systems, Inc.
BJH 24.11.21

The Cyberknife Market was valued at USD 361.06 million in 2023, expected to reach USD 448.10 million in 2024, and is projected to grow at a CAGR of 24.50%, to USD 1,674.22 million by 2030.

The Cyberknife is an advanced robotic radiosurgery system designed for non-invasive treatment of tumors and lesions throughout the body. As an innovative medical technology, its necessity lies in offering a precision-focused alternative to traditional surgical methods, thereby reducing recovery times, and targeting inoperable tumors with minimal impact on surrounding healthy tissue. Its application spans across treating conditions in the brain, spine, lung, prostate, and other areas requiring precise, high-dose radiation. The end-use scope of Cyberknife primarily includes hospitals, specialized cancer treatment centers, and research institutions. Market insights suggest an increased prevalence of cancer, growing adoption of non-invasive treatment options, and technological advancements as key growth factors. In particular, emerging markets with rising healthcare infrastructure investments present significant opportunities. Additionally, increased government support for innovative cancer therapies and an aging population drive market expansion. However, challenges such as high device costs, the requirement for skilled professionals, and competition from alternative treatments bear significant weight. To capitalize on opportunities, companies should focus on collaborative partnerships with healthcare institutions, enhance patient education about radiosurgery benefits, and invest in improving AI-based precision technologies. Innovation can flourish in areas like enhancing the machine-learning algorithms for treatment planning, developing portable versions of Cyberknife systems, and increasing the system's versatility for broader oncological applications. The competitive landscape is dynamic, with existing established players continuously upgrading platforms to maintain market leadership. Businesses should strategically focus on robust research and development combined with strategic alliances, to drive user uptake and expand market penetration. Engaging in value-based healthcare provision and customization according to patient demographics are recommended to overcome practical challenges. As the market continues to evolve, adapting to patient-specific needs and technological innovations remains pivotal for sustained growth.

KEY MARKET STATISTICS
Base Year [2023] USD 361.06 million
Estimated Year [2024] USD 448.10 million
Forecast Year [2030] USD 1,674.22 million
CAGR (%) 24.50%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cyberknife Market

The Cyberknife Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of tumor cancer patients worldwide
    • Potential demand attributed to benefits such as no blood loss, no incision and no hospitalization
    • Availability and preference for minimally invasive procedure
  • Market Restraints
    • Lack of awareness about the cyberknife procedure coupled with extremely high cost compared to other procedures
  • Market Opportunities
    • Ongoing government and private funding for the development and introduction of new product
    • Technological advancements to improve the accuracy of the procedure
  • Market Challenges
    • Shortage of skilled expertise and concerns with organizational and regulatory bodies

Porter's Five Forces: A Strategic Tool for Navigating the Cyberknife Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cyberknife Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cyberknife Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cyberknife Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cyberknife Market

A detailed market share analysis in the Cyberknife Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cyberknife Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cyberknife Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cyberknife Market

A strategic analysis of the Cyberknife Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cyberknife Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Alaska CyberKnife Center, Apollo Hospitals Enterprise Ltd, Elekta Solutions AB, Healthcare Global Enterprises Ltd., IBA Dosimetry GmbH, InterTerra Medical Technologies (India), Pvt. Ltd., MedStar Health Inc., Mevion Medical Systems, Mitsubishi Electric Corporation, Nordion (Canada) Inc. by Sotera Health, Phoenix CyberKnife, Inc., RaySearch Laboratories AB, Smith+Nephew PLC, and Varian Medical Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Cyberknife Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Brain Cancer, Liver Cancer, Lung Cancer, and Pancreas Cancer.
  • Based on End User, market is studied across Ambulatory Surgical Center, Clinic, Hospital, and Radiotherapy Center.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of tumor cancer patients worldwide
      • 5.1.1.2. Potential demand attributed to benefits such as no blood loss, no incision and no hospitalization
      • 5.1.1.3. Availability and preference for minimally invasive procedure
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of awareness about the cyberknife procedure coupled with extremely high cost compared to other procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing government and private funding for the development and introduction of new product
      • 5.1.3.2. Technological advancements to improve the accuracy of the procedure
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled expertise and concerns with organizational and regulatory bodies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cyberknife Market, by Application

  • 6.1. Introduction
  • 6.2. Brain Cancer
  • 6.3. Liver Cancer
  • 6.4. Lung Cancer
  • 6.5. Pancreas Cancer

7. Cyberknife Market, by End User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Center
  • 7.3. Clinic
  • 7.4. Hospital
  • 7.5. Radiotherapy Center

8. Americas Cyberknife Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cyberknife Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cyberknife Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accuray Incorporated
  • 2. Alaska CyberKnife Center
  • 3. Apollo Hospitals Enterprise Ltd
  • 4. Elekta Solutions AB
  • 5. Healthcare Global Enterprises Ltd.
  • 6. IBA Dosimetry GmbH
  • 7. InterTerra Medical Technologies (India), Pvt. Ltd.
  • 8. MedStar Health Inc.
  • 9. Mevion Medical Systems
  • 10. Mitsubishi Electric Corporation
  • 11. Nordion (Canada) Inc. by Sotera Health
  • 12. Phoenix CyberKnife, Inc.
  • 13. RaySearch Laboratories AB
  • 14. Smith+Nephew PLC
  • 15. Varian Medical Systems, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦